Severe hemolysis and transfusion reactions after treatment with BGB-3111 and PD-1 antibody for Waldenström macroglobulinemia

Haematologica. 2018 May;103(5):e223-e225. doi: 10.3324/haematol.2017.186817. Epub 2018 Feb 8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antineoplastic Agents / adverse effects
  • Blood Transfusion*
  • Female
  • Hemolysis / drug effects*
  • Humans
  • Middle Aged
  • Piperidines / adverse effects*
  • Prognosis
  • Programmed Cell Death 1 Receptor / immunology*
  • Pyrazoles / adverse effects*
  • Pyrimidines / adverse effects*
  • Transfusion Reaction / etiology*
  • Transfusion Reaction / pathology
  • Waldenstrom Macroglobulinemia / drug therapy*
  • Waldenstrom Macroglobulinemia / pathology

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • PDCD1 protein, human
  • Piperidines
  • Programmed Cell Death 1 Receptor
  • Pyrazoles
  • Pyrimidines
  • zanubrutinib

Associated data

  • ClinicalTrials.gov/NCT02795182